Published in Arthritis on October 31, 2012
Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS One (2014) 0.87
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. Autoimmune Dis (2013) 0.80
Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study. J Rheumatol (2014) 0.78
GDF15(MIC1) H6D Polymorphism Does Not Influence Cardiovascular Disease in a Latin American Population with Rheumatoid Arthritis. J Immunol Res (2015) 0.77
Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases. Clin Rheumatol (2014) 0.76
Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity. Saudi Med J (2015) 0.75
Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. Biomark Res (2015) 0.75
Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management. Clin Rheumatol (2017) 0.75
Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis. Clin Rheumatol (2016) 0.75
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Rheumatoid arthritis. Lancet (2010) 9.37
The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA (2004) 8.25
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
A genomewide admixture map for Latino populations. Am J Hum Genet (2007) 4.71
Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum (2005) 4.63
Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation (2003) 4.52
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
A genomewide admixture mapping panel for Hispanic/Latino populations. Am J Hum Genet (2007) 3.85
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum (2002) 3.53
Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum (2008) 2.93
Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum (2002) 2.62
CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med (2008) 2.40
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology (Oxford) (2004) 2.37
HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.28
Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) (2007) 2.22
Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum (2008) 2.21
Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation (2005) 2.03
Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol (2002) 2.01
Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ (2012) 1.94
NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis (2012) 1.90
TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis (2011) 1.81
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum (2004) 1.75
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73
Rheumatoid arthritis in African Colombians from Quibdo. Semin Arthritis Rheum (2001) 1.64
Glucocorticoids and insulin sensitivity in rheumatoid arthritis. J Rheumatol (2004) 1.62
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis (2010) 1.55
Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther (2010) 1.55
Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol (2008) 1.46
Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol (2006) 1.45
Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.42
Hypertension in rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.36
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med (2003) 1.36
The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford) (2006) 1.35
Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl (2011) 1.30
Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline. Arthritis Care Res (Hoboken) (2012) 1.28
Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis (1995) 1.26
A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther (2010) 1.20
Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol (2007) 1.19
Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) (2011) 1.16
Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol (2006) 1.16
The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther (2009) 1.15
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis (2006) 1.15
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev (2011) 1.12
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.12
Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Curr Opin Rheumatol (2005) 1.10
Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev (2011) 1.07
Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. J Clin Rheumatol (2008) 1.07
Cardiovascular diseases in Latin America and the Caribbean. Lancet (2006) 1.07
Prevalence of rheumatoid arthritis in Tucumán, Argentina. J Rheumatol (2002) 1.03
Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum (2004) 1.02
Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol (2002) 1.01
Antiphospholipid antibodies in acute coronary syndrome. Lupus (2004) 1.00
Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium (2008) 0.99
Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun Rev (2006) 0.99
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun (2008) 0.99
CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther (2011) 0.99
Vascular complications of scleroderma. Autoimmun Rev (2007) 0.97
Metabolic syndrome in rheumatological diseases. Autoimmun Rev (2009) 0.96
Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol (2012) 0.96
Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data. J Rheumatol (2007) 0.96
Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients. Lupus (2010) 0.95
Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol (2005) 0.95
Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol (2006) 0.92
Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis. Ann Rheum Dis (2008) 0.92
Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study. Rheumatol Int (2003) 0.92
Coronary and valvular syndromes and antiphospholipid antibodies. Thromb Res (2004) 0.91
Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J (2011) 0.90
Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.90
Cardiac involvement in systemic rheumatic diseases: An update. Autoimmun Rev (2010) 0.90
Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment. J Rheumatol (2010) 0.89
Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity. Arthritis Care Res (Hoboken) (2011) 0.87
Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Semin Arthritis Rheum (2008) 0.86
Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. Clin Rheumatol (2009) 0.86
Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. Joint Bone Spine (2008) 0.82
Serum oxidized low-density lipoproteins in rheumatoid arthritis. Rheumatol Int (2003) 0.82
Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Pract (2005) 0.81
Cardiovascular disease in rheumatoid arthritis: a step forward. Curr Opin Rheumatol (2010) 0.81
Antibodies against oxLDL and acute coronary syndrome. Arq Bras Cardiol (2010) 0.80
Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles. Autoimmun Rev (2004) 0.80
Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis. Curr Atheroscler Rep (2001) 0.80
Single measurements of C-reactive protein and disease activity scores are not predictors of carotid atherosclerosis in rheumatoid arthritis patients. Acta Reumatol Port (2009) 0.79
Rheumatoid arthritis and metabolic syndrome. Rev Bras Reumatol (2011) 0.78
[Analysis of the ulsefulnes of contrast echocardiography and nuclear medicine in cardiovascular affection due to autoimmune diseases]. Arch Cardiol Mex (2005) 0.78
[Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis]. Biomedica (2004) 0.77
Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis. Ethn Dis (2010) 0.76
Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol (2002) 0.76
[Ventricular diastolic dysfunction in rheumatoid arthritis]. Rev Fac Cien Med Univ Nac Cordoba (2009) 0.76
[Genetic epidemiology of rheumatoid arthritis: what to expect from Latin America?]. Biomedica (2006) 0.76
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol (2007) 3.31
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet (2011) 2.54
Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis (2013) 2.21
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet (2013) 1.79
Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med (2013) 1.56
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Hum Mol Genet (2009) 1.46
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet (2010) 1.43
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis (2011) 1.41
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41
The lupus family registry and repository. Rheumatology (Oxford) (2010) 1.21
Serious liver disease induced by infliximab. Clin Rheumatol (2006) 1.20
The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol (2007) 1.15
Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun (2011) 1.15
Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) (2005) 1.14
Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmun Rev (2011) 1.12
How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med (2013) 1.12
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev (2011) 1.12
Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol (2005) 1.11
The autoimmune tautology. Arthritis Res Ther (2010) 1.10
An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology (2010) 1.08
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis (2009) 1.08
Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) (2004) 1.08
TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect Genet Evol (2008) 1.07
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis (2012) 1.07
Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun (2008) 1.06
Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum (2010) 1.04
Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum (2004) 1.03
Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis (2012) 1.01
A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis (Edinb) (2007) 1.01
The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum (2008) 1.01
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum (2012) 1.01
Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. Rheumatology (Oxford) (2010) 1.01
Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum Immunol (2006) 1.00
Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev (2009) 0.99
Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun Rev (2006) 0.99
MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet (2013) 0.99
Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis. J Autoimmun (2008) 0.97
Prevalence and clinical features of multiple sclerosis in Latin America. Clin Neurol Neurosurg (2012) 0.97
Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis (2012) 0.96
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum (2012) 0.96
Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Clin Rev Allergy Immunol (2012) 0.96
The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis. BMC Musculoskelet Disord (2009) 0.95
ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol (2013) 0.95
The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allergy Immunol (2012) 0.95
Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun (2009) 0.94
Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J Autoimmun (2009) 0.94
Gender differences in Latin-American patients with rheumatoid arthritis. Gend Med (2012) 0.93
Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Experiment Ophthalmol (2009) 0.93
Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun Rev (2008) 0.93
Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol (2010) 0.92
Sjögren's syndrome at the crossroad of polyautoimmunity. J Autoimmun (2012) 0.92
Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth? Ann N Y Acad Sci (2009) 0.92
PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS One (2013) 0.91
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev (2008) 0.91
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One (2012) 0.91
Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction. J Rheumatol (2011) 0.90
Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. PLoS Genet (2013) 0.90
HLA-Class II in Latin American patients with type 1 diabetes. Autoimmun Rev (2010) 0.90
The nature and nurture of common autoimmunity. Ann N Y Acad Sci (2007) 0.90
Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev (2012) 0.90
Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience. J Clin Rheumatol (2012) 0.90
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum (2011) 0.89
Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. PLoS Genet (2013) 0.89
Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum Immunol (2006) 0.89
Primary biliary cirrhosis and the nuclear pore complex. Autoimmun Rev (2012) 0.89
Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases? Clin Rev Allergy Immunol (2008) 0.89
Systemic sclerosis: a world wide global analysis. Clin Rheumatol (2009) 0.89
Genetics and autoantibodies. Immunol Res (2013) 0.88
IgM predominance in autoimmune disease: genetics and gender. Autoimmun Rev (2011) 0.88
The impact of disease activity on the quality of life, mental health status, and family dysfunction in colombian patients with rheumatoid arthritis. J Clin Rheumatol (2003) 0.87
HLA class II polymorphism in Latin American patients with multiple sclerosis. Autoimmun Rev (2009) 0.86
The IkappaBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjögren's syndrome. Hum Immunol (2007) 0.86
Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. Clin Rheumatol (2009) 0.86
Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Semin Arthritis Rheum (2008) 0.86
Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J Rheumatol (2004) 0.86
Influence of STAT4 polymorphism in primary Sjögren's syndrome. J Rheumatol (2010) 0.85
What is next after the genes for autoimmunity? BMC Med (2013) 0.85
Relation of sensory peripheral neuropathy in Sjögren syndrome to anti-Ro/SSA. J Clin Rheumatol (2012) 0.85